Literature DB >> 3974893

Clinical correlations of serial somatosensory evoked potentials in multiple sclerosis.

S L Davis, M J Aminoff, H S Panitch.   

Abstract

Serial median nerve somatosensory evoked potentials (SEPs) were recorded in 12 patients with definite MS. On the initial tests, there was no clear association between the severity of clinical disease activity and SEP findings. The cervical response was most frequently affected and, when present, was often abnormal in configuration, suggesting absence or delay in the far field P14 component with preservation of cervical N11 and N13 components. Clinical motor and sensory findings in the corresponding limb frequently correlated with abnormalities of the cervical response. When new motor and sensory findings developed in the arms during the study, the SEP deteriorated in some patients but improved in others. Most SEP changes were not accompanied by clinical changes. Overall disability sometimes increased during the study despite improvements in the SEP.

Entities:  

Mesh:

Year:  1985        PMID: 3974893     DOI: 10.1212/wnl.35.3.359

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroid treatment.

Authors:  V Scaioli; C Milanese; A Salmaggi; L LaMantia; A Campi; M Eoli; F Panzica
Journal:  Ital J Neurol Sci       Date:  1992-03

2.  Stimulation of motor tracts in multiple sclerosis.

Authors:  A Berardelli; M Inghilleri; G Cruccu; M Fornarelli; N Accornero; M Manfredi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

3.  Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.

Authors:  L Leocani; M Rovaris; F M Boneschi; S Medaglini; P Rossi; V Martinelli; S Amadio; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-30       Impact factor: 10.154

4.  Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis.

Authors:  Gençer Genç; Şeref Demirkaya; Semai Bek; Zeki Odabaşi
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.